MTA2 and prostate cancer: In addition, tissues expressing high IFNA17 levels were negatively correlated with AR-responsive gene signatures, as revealed by GSEAs in TCGA prostate cancer datasets (GO, Nelson, Wang, PID; Fig. 4L).